South West Wales Cancer Centre
Swansea, United Kingdom
NCT Number: NCT06142071
The main questions the study aims to answer are:
1. The proportion of family members of cancer patients who say they need more support 2. What support family members feel would be beneficial
Information about patients' cancer diagnosis and treatment will be collected from their medical notes.
Participating family members will be asked to complete a telephone questionnaire. Selected family members may also be asked to participate in an optional follow-up interview.
This study is active but is not currently recruiting participants.
When someone is diagnosed with cancer, it can be a worrying and stressful time for patients and for their family members. Family members may provide practical and emotional support to patients, and may take on a caregiver role.
Family members may want more information or advice, or may benefit from emotional support themselves. The study aims to identify any gaps in the current support provided to family members so that services can be improved in the future.
Oncology patients in Singleton Hospital, Swansea will be asked by their oncology team to identify one or more family members to participate in the study. If a family member agrees to participate in the study, the research team will call them to complete a telephone questionnaire. The questionnaire should take less than 20 minutes and asks them some general questions (e.g. age, gender) and some questions about how they are feeling, what support services they find helpful and what additional support they feel would be beneficial.
Data regarding participating patients' cancer diagnosis and treatment will be collected from their medical notes.
After the questionnaire data has been analysed, optional follow-up interviews will be conducted with some family members to explore any issues identified in greater detail.
Patients and family members will be recruited during a 6 month recruitment period and all responses will be anonymised.
This is a pilot study which will not change the current support provided to family members, although they may be directed to existing services if appropriate. Patients' treatment will not be changed in any way.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for patients
Inclusion criteria
for family members
Exclusion criteria
for patients and family members
Telephone questionnaire, which includes questions on participant's demographics, anxiety/depression scores, what support they find helpful and what additional support they feel would be beneficial
Time frame: 6 months after start of study recruitment
The proportion of family members who state they need more support
Time frame: 6 months after start of study recruitment
he proportion of family members who state they need more support with each of the Carer Support Needs Assessment Tool (CSNAT) domains
Time frame: 6 months after start of study recruitment
This will be determined by qualitative analysis of questionnaire and interview data and may include improved psychological support, online resources, information leaflets etc
Swansea Bay University Health Board
Other
Acronym: SALUTE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01169259
Cancer, Cardiovascular Disease
Boston, Massachusetts, United States
View Trial DetailsNCT07076004
Cancer, Neoplasms
New Haven, Connecticut, United States
View Trial DetailsNCT00339495
Cancer, Death
Rockville, Maryland, United States
View Trial DetailsNCT07729241
COVID-19, COVID-19 Vaccination
Paris, France
View Trial Details